Results 51 to 60 of about 27,075 (176)

Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children. [PDF]

PLoS ONE, 2010
Where P. vivax and P. falciparum occur in the same population, the peak burden of P. vivax infection and illness is often concentrated in younger age groups. Experiences from malaria therapy patients indicate that immunity is acquired faster to P.
Enmoore Lin, Benson Kiniboro, Laurie Gray, Stuart Dobbie, Leanne Robinson, Annemarie Laumaea, Sonja Schöpflin, Danielle Stanisic, Inoni Betuela, Melinda Blood-Zikursh, Peter Siba, Ingrid Felger, Louis Schofield, Peter Zimmerman, Ivo Mueller   +14 more
doaj   +1 more source

Health Screening and Post‐Arrival Services for Refugee Children From Afghanistan

Journal of Paediatrics and Child Health, Volume 62, Issue 8, Page 1403-1410, August 2026.
ABSTRACT Aim To examine refugee health screening and services for Afghan children in the unique context of emergency expedited humanitarian resettlement in Melbourne, Australia. Methods Retrospective audit of Afghan children who attended a specialist child refugee health service between August 2021–April 2024. Results Participants included 218 children
Amy Williamson, Eva Sudbury, Rija Khanal, Jade Woon, Jennifer Schaefer, Georgia Paxton   +5 more
wiley   +1 more source

METODE PENENTUAN RESISTENSI PLASMODIUM VIVAX TERHADAP KLOROKUIN

Majalah Kedokteran Andalas, 2008
AbstrakKlorokuin merupakan obat pilihan pertama selama lebih kurang 50 tahun untuk pengobatan malaria vivax, karena kerjanya cepat, murah, dan aman diberikan pada bayi dan wanita hamil. Sejak 1989 muncul beberapa laporan resistensi P.
Nurhayati Nurhayati
doaj   +1 more source

Short‐Course Low‐Dose Primaquine for Radical Cure in G6PD‐Normal Patients in the Pre‐Elimination Context of Nepal

Tropical Medicine &International Health, Volume 31, Issue 8, Page 1028-1034, August 2026.
ABSTRACT Background Plasmodium vivax remains a challenge for malaria elimination in Nepal due to its ability to relapse. Radical cure with primaquine is effective but limited by poor adherence to the standard 14‐day low‐dose regimen. In 2022, the WHO recommended administering the same total dose (3.5 mg/kg) over 7 days to improve adherence.
Prakash Ghimire, Gokarna Dahal, Nabaraj Adhikari, Komal Raj Rijal, Sanjib Adhikari, Megha Raj Banjara, Hellen Mnjala, Grant Lee, Sophie Weston, Angela Rumaseb, Anjana Rai, Benedikt Ley, Mohammad Sharif Hossain, Julie A. Simpson, Megha Rajasekhar, Bipin Adhikari, Ric N. Price, Bibek K. Lal, Kamala Thriemer   +18 more
wiley   +1 more source

Diagnosing P. simium zoonotic malaria infection in the Rio de Janeiro Atlantic forest, Brazil

Scientific Reports
Malaria remains a pressing health challenge in Brazil, primarily due to Plasmodium vivax. Most cases occur in the Amazon; however, outbreaks in the Atlantic Forest involving P. simium, a non-human primate parasite closely related to P.
Maria de Fátima Ferreira-da-Cruz, Natália Ketrin Almeida-de-Oliveira, Rebecca de Abreu-Fernandes, Aline Rosa de Lavigne Mello, Graziela Zanini, Filipe Vieira Santos de Abreu, Anielle de Pina-Costa, Ricardo Lourenço-de-Oliveira, Patrícia Brasil, Cláudio Tadeu Daniel-Ribeiro   +9 more
doaj   +1 more source

Immune Response and Microbiota Profiles during Coinfection with Plasmodium vivax and Soil-Transmitted Helminths

mBio, 2020
The role of the gut microbiota during coinfection with soil-transmitted helminths (STH) and Plasmodium spp. is poorly understood. We examined peripheral blood and fecal samples from 130 individuals who were either infected with Plasmodium vivax only ...
Alice V. Easton, Mayra Raciny-Aleman, Victor Liu, Erica Ruan, Christian Marier, Adriana Heguy, Maria Fernanda Yasnot, Ana Rodriguez, P’ng Loke   +8 more
doaj   +1 more source

Hit‐To‐Lead Optimization of a Pyridylpiperazine Class Against Malaria: Pharmacokinetic Profile and In Vivo Efficacy of Optimized Compounds

ChemMedChem, Volume 21, Issue 13, 14 July 2026.
Chemical optimization of a novel pyridylpiperazine class yields two promising antimalarial candidates with an exceptional balance of metabolic stability and solubility. These optimized leads significantly protect mice from cerebral malaria, reducing parasitic load by up to 91.7%.
Douglas Davison da Silva Oliveira, Duarte Eduardo Pereira, Rafael Consolin Chelucci, Simone Michelan, Júlia Maria Fernandes Pituba, Adriano D. Andricopulo, Leonardo L. G. Ferreira, Neide Maria Silva, Celso de Oliveira Rezende Júnior   +8 more
wiley   +1 more source

Sub-RDT Plasmodium vivax infections and G6PD deficiency in Kayin State, Myanmar

Malaria Journal
Background In Kayin State (Myanmar), Plasmodium falciparum incidence declined substantially between 2014 and 2020 following intensive elimination efforts, leaving P. vivax as the predominant species. Elimination of P. vivax is challenging due to relapses,
Aung Myint Thu, Aung Pyae Phyo, Chanapat Pateekham, Saw Hay Blu, May Myo Thwin, Ladda Kajeechiwa, Wanitda Watthanaworawit, Yanada Okkararungrot, Germana Bancone, Gornpan Gornsawun, Paw Khu Moo, Khaung Klain, Pyae Linn Aung, Wang Nguitragool, Wirichada Pan-ngum, François Nosten   +15 more
doaj   +1 more source

Microsatellite Genotyping of Plasmodium vivax Isolates from Pregnant Women in Four Malaria Endemic Countries. [PDF]

PLoS ONE, 2016
Plasmodium vivax is the most widely distributed human parasite and the main cause of human malaria outside the African continent. However, the knowledge about the genetic variability of P. vivax is limited when compared to the information available for P.
Michela Menegon, Azucena Bardají, Flor Martínez-Espinosa, Camila Bôtto-Menezes, Maria Ome-Kaius, Ivo Mueller, Inoni Betuela, Myriam Arévalo-Herrera, Swati Kochar, Sanjay K Kochar, Puneet Jaju, Dhiraj Hans, Chetan Chitnis, Norma Padilla, María Eugenia Castellanos, Lucía Ortiz, Sergi Sanz, Mireia Piqueras, Meghna Desai, Alfredo Mayor, Hernando Del Portillo, Clara Menéndez, Carlo Severini   +22 more
doaj   +1 more source

ACKR1/Duffy‐null genotype testing for clozapine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

British Journal of Clinical Pharmacology, Volume 92, Issue 7, Page 1977-1990, July 2026.
Abstract Clozapine is licenced for treatment‐resistant schizophrenia and psychosis in Parkinson's disease. In the United Kingdom, there is a mandatory requirement for absolute neutrophil count (ANC) and white blood cell count (WBC) monitoring to safeguard against agranulocytosis.
Stephen Murtough, Oriella Stellakis, Daisy Mills, Blanca Bjourson, Vicky Chaplin, Dharmisha Chauhan, Bev Chipp, Marius Cotic, Jana de Villiers, Olubanké Dzahini, Frances Elmslie, Katie Evans, Shreyans Gandhi, Dyfrig A. Hughes, Huajie Jin, Daniele Panconesi, Anna Skowronska, Sanjay M. Sisodiya, Ed Silva, Vicky Stinton, Sara Stuart‐Smith, Sarah Tarrant, David Taylor, Lauren Varney, James T. R. Walters, Michelle Wood, Jessica Woodley, Cinzia Dello Russo, Munir Pirmohamed, Elvira Bramon   +29 more
wiley   +1 more source